ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

C Maaser, A Sturm, SR Vavricka… - Journal of Crohn's …, 2019 - academic.oup.com
This new diagnostic consensus guideline is a joint project of the European Crohn's and
Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal …

Calprotectin in inflammatory bowel disease

F Khaki-Khatibi, D Qujeq, M Kashifard, S Moein… - Clinica chimica acta, 2020 - Elsevier
The term IBD is usually used for referring to a group of inflammatory gastro-intestinal
diseases (mainly Crohn's disease and ulcerative colitis). Accordingly, IBD arises as a result …

ACG clinical guideline: ulcerative colitis in adults

DT Rubin, AN Ananthakrishnan… - Official journal of the …, 2019 - journals.lww.com
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

Clinical value of fecal calprotectin

A Ricciuto, AM Griffiths - Critical reviews in clinical laboratory …, 2019 - Taylor & Francis
Inflammatory bowel disease (IBD) denotes a group of chronic incurable disorders
characterized by relapsing-remitting inflammation of the gastrointestinal tract. IBD represents …

faecal calprotectin and histologic remission in ulcerative colitis

F D'Amico, S Bonovas, S Danese… - Alimentary …, 2020 - Wiley Online Library
Background Histologic healing is emerging as a new therapeutic goal in both routine
practice and clinical trials in ulcerative colitis (UC). However, it requires repeated …

Faecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2—a comparative study

A Zollner, A Schmiderer, SJ Reider… - Journal of Crohn's …, 2021 - academic.oup.com
Abstract Background and Aims Faecal biomarkers, particularly calprotectin [FCAL], have
become important diagnostic and monitoring tools in inflammatory bowel diseases [IBD]. As …

Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults

M Krzystek-Korpacka, R Kempiński, M Bromke… - Diagnostics, 2020 - mdpi.com
Mucosal healing (MH) is the key therapeutic target of inflammatory bowel disease (IBD). The
evaluation of MH remains challenging, with endoscopy being the golden standard. We …

[HTML][HTML] Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

F Zou, X Wang, ICG Oliva, JL McQuade… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Immune-mediated diarrhea and colitis (IMDC) is currently diagnosed and
monitored by evaluating clinical symptoms. Deep remission is determined by endoscopic …

Neutrophil–T cell crosstalk in inflammatory bowel disease

E Kvedaraite - Immunology, 2021 - Wiley Online Library
Neutrophils are the most abundant leucocytes in human blood, promptly recruited to the site
of tissue injury, where they orchestrate inflammation and tissue repair. The multifaceted …

Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study

W Feng, Y Liu, L Zhu, L Xu, H Shen - BMC gastroenterology, 2022 - Springer
Purpose Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder affecting the
large intestine. Inflammatory biomarkers in UC are nonspecific, simple and cheap biomarker …